home / stock / lci / lci news


LCI News and Press, Lannett Co Inc From 12/20/19

Stock Information

Company Name: Lannett Co Inc
Stock Symbol: LCI
Market: NYSE

Menu

LCI LCI Quote LCI Short LCI News LCI Articles LCI Message Board
Get LCI Alerts

News, Short Squeeze, Breakout and More Instantly...

LCI - Mixed shelf roundup

Healthcare companies filing for mixed shelf offerings: More news on: Lannett Company, Inc., AVROBIO, Inc., UroGen Pharma Ltd., Healthcare stocks news, Read more ...

LCI - Lannett To Commence Marketing Generic Adderall® XR

PHILADELPHIA , Dec. 12, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it expects to commence marketing in the coming months a generic version of Adderall XR ® , an extended-release mixed salt of a single entity Amphetamine tablet product (Dextroamph...

LCI - Lannett: Building Success One Step At A Time

It has long been said, and as history proves, bad things happen to good people. And it follows that bad things happen to good companies. Good companies fail. Evidence? How about a quick comparison of the Fortune 25 for the year 2000 to that for the year 2019 finds only 8 companies from the 2...

LCI - GPRO, CLVS among premarket gainers

Schmitt Industries (NASDAQ: SMIT ) +13%  on $2M stock repurchase plan . More news on: Schmitt Industries, Inc., EyePoint Pharmaceuticals, Inc., Kodiak Sciences Inc., Stocks on the move, Read more ...

LCI - Lannett up 4% premarket on advancement of Lantus biosimilar

Lannett Company (NYSE: LCI ) announces positive results from the first human study evaluating it and alliance partner HEC Group's insulin glargine, a biosimilar to Sanofi's (NASDAQ: SNY ) top diabetes seller Lantus. More news on: Lannett Company, Inc., Sanofi, Healthcare stocks news, Sto...

LCI - Lannett Announces Positive Results From Human Clinical Trial Of Biosimilar Insulin Glargine Versus US Lantus®

PHILADELPHIA , Dec. 4, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced positive results from the first human study evaluating insulin glargine that Lannett is developing with its strategic alliance partners within the HEC Group of companies (HEC).  Insulin glar...

LCI - Lannett enters new insulin glargine deal with HEC

Lannett (NYSE: LCI ) says in a filing that it's entered into a new collaboration and license agreement with HEC. More news on: Lannett Company, Inc., Healthcare stocks news, Read more ...

LCI - Lannett Inc (LCI) Q1 2020 Earnings Call Transcript

Image source: The Motley Fool. Lannett Inc   (NYSE: LCI) Q1 2020 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading

LCI - Lannett Company's (LCI) CEO Tim Crew on Q1 2020 Results - Earnings Call Transcript

Lannett Company, Inc. (LCI) Q1 2020 Earnings Conference Call November 06, 2019 4:30 PM ET Company Participants Robert Jaffe – Investor Relations Tim Crew – Chief Executive Officer John Kozlowski – Chief Financial Officer Conference Call Participants Ell...

LCI - Lannett FQ1 top line down 18% as pricing headwinds continue; shares down 4% AH

Lannett Company (NYSE: LCI ) fiscal Q1 results : More news on: Lannett Company, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

Previous 10 Next 10